Presidential Healthcare center

We provide the same Preventive Executive Physical Program as received by the President of the United States.


Leave a comment

Hepatitis C Infection May Fuel Heart Risk

HEP C 2People infected with the hepatitis C virus are at risk for liver damage, but the results of a new Johns Hopkins study now show the infection may also spell heart trouble.

The findings, described online July 27 in The Journal of Infectious Diseases, emerged from a larger ongoing study of men who have sex with men, many but not all of whom were infected with HIV and followed over time to track risk of infection and disease progression. A subset of the participants had both HIV and hepatitis C, two infections that often occur together.

Even though people infected with HIV are already known to have an elevated risk for heart disease, researchers emphasize their results offer strong evidence that hepatitis C can spark cardiovascular damage independent of HIV.

Specifically, the research found that study participants chronically infected with hepatitis C were more likely to harbor abnormal fat-and-calcium plaques inside their arteries, a condition known as atherosclerosis and a common forerunner of heart attacks and strokes.

“We have strong reason to believe that infection with hepatitis C fuels cardiovascular disease, independent of HIV and sets the stage for subsequent cardiovascular trouble,” says study principal investigator Eric Seaberg, Ph.D., assistant professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. “We believe our HEP C 3findings are relevant to anyone infected with hepatitis C regardless of HIV status.”

Investigators emphasize they don’t know exactly how infection with the hepatitis C virus precipitates the growth of artery-clogging plaque but that their evidence is strong enough to warrant vigilant monitoring for cardiac symptoms among people infected with the virus.

“People infected with hepatitis C are already followed regularly for signs of liver disease, but our findings suggest clinicians who care for them should also assess their overall cardiac risk profile regularly,” says study author Wendy Post, M.D., M.S., professor of medicine at the Johns Hopkins University School of Medicine and a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease.

Source: Johns Hopkins Bloomberg School of Public Health

The Presidential Healthcare Center provides Hepatitis Screening and Vaccinations.


Leave a comment

World Hepatitis Day — July 28th

Every year on July 28th, World Hepatitis Day aims to increase the awareness and understanding of viral hepatitis as aHEP c major global health threat. All types of viral hepatitis can cause inflammation of the liver; however, hepatitis B and C infection can result in a lifelong, chronic infection.

The World Health Organization (WHO) estimates that nearly 400 million people have chronic viral hepatitis worldwide and most of them do not know they are infected. More than 1 million people die each year from causes related to viral hepatitis, commonly cirrhosis and liver cancer.

Hepatitis A:

  • Hepatitis A is a liver disease caused by the hepatitis A virus that can cause mild to severe illness but does not lead to chronic infection.
  • Globally, there are an estimated 1.4 million cases of hepatitis A every year.HEP 1
  • The hepatitis A virus is spread by ingestion of contaminated food and water, or through direct contact with an infectious person.

Hepatitis B:

  • Hepatitis B is a serious liver disease caused by the hepatitis B virus that can cause both acute and chronic disease.
  • Globally, there are an estimated 240 million people living with chronic Hepatitis B.
  • The hepatitis B virus is spread through contact with the blood or other body fluids of an infected person.
  • There is a safe and effective vaccine available to prevent Hepatitis B.
  • The best way to prevent getting infected with Hepatitis B is to get vaccinated.  In the United States, the Hepatitis B vaccine is recommended for all babies at birth and adults at risk of infection.  HEP 2

Hepatitis C:

  • Hepatitis C is a serious liver disease caused by the hepatitis C virus that can cause both acute and chronic disease.
  • Globally, there are an estimated 130–150 million people living with chronic Hepatitis C.
  • The hepatitis C virus is a bloodborne virus.
  • There is currently no vaccine for hepatitis C.

Source: CDC


Leave a comment

Acute Hepatitis and Liver Failure Following Use of Dietary Supplement

The Hawaii Department of Health (HDOH) was notified of seven patients with severe acute hepatitis and fulminant liver failure of unknown etiology. Patients were previously healthy and sought medical care during May-September 2013. Clinicians reported that the seven patients had all used OxyElite Pro, a dietary supplement marketed for weight loss and muscle gain, before illness onset.The HDOH, with the CDC and the Food and Drug Administration (FDA), initiated a public health investigation including patient interviews, medical chart reviews, and collection of supplement samples for analysis. Results from FDA product testing are pending. While the investigation is ongoing and these data are preliminary, clinical data, laboratory tests, and histopathology of liver biopsy specimens collected thus far suggest drug- or herb-induced hepatotoxicity. Drug- and herb-induced hepatotoxicity have been reported in association with exposure to a variety of drugs and herbs used as dietary supplements and can lead to severe acute hepatitis and liver failure.

Source: Center for Disease Control and Prevention